Christopher J. Twomey - May 24, 2023 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ Rachel Malina, Attorney-in-Fact for Christopher J. Twomey
Stock symbol
TNDM
Transactions as of
May 24, 2023
Transactions value $
$0
Form type
4
Date filed
5/26/2023, 04:13 PM
Previous filing
Jun 13, 2022
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +2.76K +67.29% $0.00 6.85K May 25, 2023 Direct
holding TNDM Common Stock 5.11K May 24, 2023 See Footnote F1
holding TNDM Common Stock 7.57K May 24, 2023 See Footnotes F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM RSU 2023 05 24 Options Exercise $0 +4.43K $0.00 4.43K May 24, 2023 Common Stock 4.43K Direct F3, F4, F5
transaction TNDM Restricted Stock Unit Options Exercise $0 -2.76K -100% $0.00* 0 May 25, 2023 Common Stock 2.76K Direct F6, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.
F2 The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over thesesecurities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held byTwomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.
F3 Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F4 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F5 RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
F6 Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F7 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F8 RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.